

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.93693331 |
| 2 | signal peptide processing (GO:0006465) | 4.62641833 |
| 3 | Golgi transport vesicle coating (GO:0048200) | 4.56682965 |
| 4 | COPI coating of Golgi vesicle (GO:0048205) | 4.56682965 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 3.96406022 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.96406022 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 3.77151109 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.77151109 |
| 9 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.74843435 |
| 10 | negative regulation of protein localization to plasma membrane (GO:1903077) | 3.62831529 |
| 11 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.61785392 |
| 12 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.50471727 |
| 13 | protein retention in ER lumen (GO:0006621) | 3.48883785 |
| 14 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.48792640 |
| 15 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.48792640 |
| 16 | peptide catabolic process (GO:0043171) | 3.44406537 |
| 17 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 3.42890873 |
| 18 | intestinal absorption (GO:0050892) | 3.36907086 |
| 19 | nucleotide-sugar metabolic process (GO:0009225) | 3.36238617 |
| 20 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.33451309 |
| 21 | nitrogen cycle metabolic process (GO:0071941) | 3.30553651 |
| 22 | regulation of metalloenzyme activity (GO:0048552) | 3.28106506 |
| 23 | regulation of early endosome to late endosome transport (GO:2000641) | 3.25850668 |
| 24 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.22277255 |
| 25 | COPII vesicle coating (GO:0048208) | 3.20733927 |
| 26 | aldehyde catabolic process (GO:0046185) | 3.19379906 |
| 27 | protein maturation by protein folding (GO:0022417) | 3.17117823 |
| 28 | protein localization to endosome (GO:0036010) | 3.13376494 |
| 29 | intestinal cholesterol absorption (GO:0030299) | 3.13298517 |
| 30 | desmosome organization (GO:0002934) | 3.13140610 |
| 31 | aromatic amino acid family catabolic process (GO:0009074) | 3.12001488 |
| 32 | nucleobase catabolic process (GO:0046113) | 3.11678819 |
| 33 | actin nucleation (GO:0045010) | 3.08856076 |
| 34 | lipoprotein transport (GO:0042953) | 3.06480991 |
| 35 | uronic acid metabolic process (GO:0006063) | 3.05721504 |
| 36 | glucuronate metabolic process (GO:0019585) | 3.05721504 |
| 37 | sequestering of metal ion (GO:0051238) | 3.01833949 |
| 38 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.99013164 |
| 39 | cellular ketone body metabolic process (GO:0046950) | 2.97798541 |
| 40 | hypotonic response (GO:0006971) | 2.97355912 |
| 41 | cell adhesion mediated by integrin (GO:0033627) | 2.96614009 |
| 42 | cysteine metabolic process (GO:0006534) | 2.94707894 |
| 43 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.92344726 |
| 44 | embryonic process involved in female pregnancy (GO:0060136) | 2.90487247 |
| 45 | ethanol oxidation (GO:0006069) | 2.90163933 |
| 46 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.86702077 |
| 47 | protein-lipid complex assembly (GO:0065005) | 2.86395870 |
| 48 | ER overload response (GO:0006983) | 2.85750060 |
| 49 | cofactor catabolic process (GO:0051187) | 2.85593418 |
| 50 | sulfur amino acid catabolic process (GO:0000098) | 2.85272620 |
| 51 | epoxygenase P450 pathway (GO:0019373) | 2.84978054 |
| 52 | plasma lipoprotein particle assembly (GO:0034377) | 2.83948054 |
| 53 | low-density lipoprotein particle remodeling (GO:0034374) | 2.83632154 |
| 54 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 2.83389157 |
| 55 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.83351211 |
| 56 | cellular glucuronidation (GO:0052695) | 2.83131543 |
| 57 | membrane budding (GO:0006900) | 2.81688751 |
| 58 | NADH metabolic process (GO:0006734) | 2.81010907 |
| 59 | respiratory burst (GO:0045730) | 2.80092136 |
| 60 | drug transmembrane transport (GO:0006855) | 2.79673819 |
| 61 | peptidyl-asparagine modification (GO:0018196) | 2.76711629 |
| 62 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.75773155 |
| 63 | regulation of protein activation cascade (GO:2000257) | 2.75308500 |
| 64 | flavonoid metabolic process (GO:0009812) | 2.74169589 |
| 65 | diterpenoid biosynthetic process (GO:0016102) | 2.73962977 |
| 66 | regulation of protein localization to plasma membrane (GO:1903076) | 2.72432865 |
| 67 | regulation of complement activation (GO:0030449) | 2.72297807 |
| 68 | regulation of cholesterol homeostasis (GO:2000188) | 2.71911532 |
| 69 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.71884162 |
| 70 | fibrinolysis (GO:0042730) | 2.71102091 |
| 71 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.69769599 |
| 72 | lipopolysaccharide metabolic process (GO:0008653) | 2.68964361 |
| 73 | mitochondrial calcium ion transport (GO:0006851) | 2.68652324 |
| 74 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.66915853 |
| 75 | platelet degranulation (GO:0002576) | 2.66085420 |
| 76 | positive regulation of extracellular matrix organization (GO:1903055) | 2.65936577 |
| 77 | neutrophil activation involved in immune response (GO:0002283) | 2.65765031 |
| 78 | regulation of establishment of protein localization to plasma membrane (GO:0090003) | 2.64467612 |
| 79 | coenzyme catabolic process (GO:0009109) | 2.62785494 |
| 80 | regulation of cholesterol esterification (GO:0010872) | 2.62564278 |
| 81 | protein N-linked glycosylation (GO:0006487) | 2.62297137 |
| 82 | vesicle coating (GO:0006901) | 2.61384453 |
| 83 | blood coagulation, intrinsic pathway (GO:0007597) | 2.59260672 |
| 84 | alkaloid metabolic process (GO:0009820) | 2.58681818 |
| 85 | regulation of substrate adhesion-dependent cell spreading (GO:1900024) | 2.58435008 |
| 86 | phospholipid scrambling (GO:0017121) | 2.58337974 |
| 87 | bile acid and bile salt transport (GO:0015721) | 2.58335214 |
| 88 | cyclooxygenase pathway (GO:0019371) | 2.55685455 |
| 89 | barbed-end actin filament capping (GO:0051016) | 2.53997659 |
| 90 | positive regulation of hemostasis (GO:1900048) | 2.53955703 |
| 91 | positive regulation of blood coagulation (GO:0030194) | 2.53955703 |
| 92 | ribonucleoside bisphosphate metabolic process (GO:0033875) | 2.53513189 |
| 93 | nucleoside bisphosphate metabolic process (GO:0033865) | 2.53513189 |
| 94 | purine nucleoside bisphosphate metabolic process (GO:0034032) | 2.53513189 |
| 95 | negative regulation of blood coagulation (GO:0030195) | 2.53421836 |
| 96 | negative regulation of hemostasis (GO:1900047) | 2.53421836 |
| 97 | proline biosynthetic process (GO:0006561) | 2.53131312 |
| 98 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.52830504 |
| 99 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.52662595 |
| 100 | fructose metabolic process (GO:0006000) | 2.51597070 |
| 101 | negative regulation of protein activation cascade (GO:2000258) | 2.51443298 |
| 102 | hormone catabolic process (GO:0042447) | 2.50301047 |
| 103 | daunorubicin metabolic process (GO:0044597) | 2.49782671 |
| 104 | polyketide metabolic process (GO:0030638) | 2.49782671 |
| 105 | doxorubicin metabolic process (GO:0044598) | 2.49782671 |
| 106 | GDP-mannose metabolic process (GO:0019673) | 2.49467497 |
| 107 | thrombin receptor signaling pathway (GO:0070493) | 2.49213578 |
| 108 | response to thyroid hormone (GO:0097066) | 2.48916150 |
| 109 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.48667664 |
| 110 | iron ion import (GO:0097286) | 2.48458967 |
| 111 | drug transport (GO:0015893) | 2.47898780 |
| 112 | negative regulation of fibrinolysis (GO:0051918) | 2.47050914 |
| 113 | negative regulation of coagulation (GO:0050819) | 2.46996820 |
| 114 | ethanol metabolic process (GO:0006067) | 2.46913595 |
| 115 | ketone body metabolic process (GO:1902224) | 2.45457210 |
| 116 | alpha-linolenic acid metabolic process (GO:0036109) | 2.44518823 |
| 117 | peroxisome fission (GO:0016559) | 2.44298733 |
| 118 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.43670040 |
| 119 | progesterone metabolic process (GO:0042448) | 2.43126669 |
| 120 | cholesterol biosynthetic process (GO:0006695) | 2.42004244 |
| 121 | positive regulation of macrophage differentiation (GO:0045651) | 2.41269896 |
| 122 | angiotensin maturation (GO:0002003) | 2.40456549 |
| 123 | regulation of triglyceride catabolic process (GO:0010896) | 2.39225584 |
| 124 | homocysteine metabolic process (GO:0050667) | 2.39044683 |
| 125 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.38805863 |
| 126 | triglyceride catabolic process (GO:0019433) | 2.38118387 |
| 127 | protein-lipid complex subunit organization (GO:0071825) | 2.37872634 |
| 128 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.37573735 |
| 129 | regulation of extracellular matrix disassembly (GO:0010715) | 2.37317192 |
| 130 | positive regulation of coagulation (GO:0050820) | 2.36869917 |
| 131 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.36102714 |
| 132 | negative regulation of wound healing (GO:0061045) | 2.35281165 |
| 133 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.34780427 |
| 134 | high-density lipoprotein particle remodeling (GO:0034375) | 2.34651435 |
| 135 | glycoside metabolic process (GO:0016137) | 2.34341434 |
| 136 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.34252774 |
| 137 | protein carboxylation (GO:0018214) | 2.34252774 |
| 138 | negative regulation of complement activation (GO:0045916) | 2.33743961 |
| 139 | plasma lipoprotein particle organization (GO:0071827) | 2.33478713 |
| 140 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.32950624 |
| 141 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.32702474 |
| 142 | regulation of lipoprotein metabolic process (GO:0050746) | 2.32679114 |
| 143 | primary alcohol catabolic process (GO:0034310) | 2.31281958 |
| 144 | glycosphingolipid catabolic process (GO:0046479) | 2.31092434 |
| 145 | tryptophan metabolic process (GO:0006568) | 2.31000907 |
| 146 | complement activation, classical pathway (GO:0006958) | 2.30957675 |
| 147 | endocrine pancreas development (GO:0031018) | 2.30768931 |
| 148 | NADPH regeneration (GO:0006740) | 2.30483837 |
| 149 | thioester biosynthetic process (GO:0035384) | 2.30016810 |
| 150 | acyl-CoA biosynthetic process (GO:0071616) | 2.30016810 |
| 151 | negative regulation of fatty acid transport (GO:2000192) | 2.29781168 |
| 152 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.29754829 |
| 153 | response to vitamin E (GO:0033197) | 2.29506871 |
| 154 | tryptophan catabolic process (GO:0006569) | 2.28383710 |
| 155 | indole-containing compound catabolic process (GO:0042436) | 2.28383710 |
| 156 | indolalkylamine catabolic process (GO:0046218) | 2.28383710 |
| 157 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.28064585 |
| 158 | drug catabolic process (GO:0042737) | 2.27806750 |
| 159 | peptide hormone processing (GO:0016486) | 2.27406158 |
| 160 | sulfation (GO:0051923) | 2.27404448 |
| 161 | acylglycerol catabolic process (GO:0046464) | 2.25993923 |
| 162 | neutral lipid catabolic process (GO:0046461) | 2.25993923 |
| 163 | bile acid metabolic process (GO:0008206) | 2.25930368 |
| 164 | NADP metabolic process (GO:0006739) | 2.25122418 |
| 165 | aromatic amino acid family metabolic process (GO:0009072) | 2.21872578 |
| 166 | bile acid biosynthetic process (GO:0006699) | 2.21799132 |
| 167 | cytidine deamination (GO:0009972) | 2.21021189 |
| 168 | cytidine metabolic process (GO:0046087) | 2.21021189 |
| 169 | cytidine catabolic process (GO:0006216) | 2.21021189 |
| 170 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.20913101 |
| 171 | urea metabolic process (GO:0019627) | 2.20724636 |
| 172 | urea cycle (GO:0000050) | 2.20724636 |
| 173 | transcytosis (GO:0045056) | 2.20667829 |
| 174 | phenylpropanoid metabolic process (GO:0009698) | 2.20409552 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.07625977 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.98163640 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.86757877 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.72971316 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.41501513 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.28059359 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.13140293 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.02406802 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 2.75376021 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.73273746 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.72315854 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.70801938 |
| 13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.69670732 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.65221722 |
| 15 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.61204413 |
| 16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.57280631 |
| 17 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.52254782 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.34695477 |
| 19 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.25424110 |
| 20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.23571807 |
| 21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.21797337 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.18108934 |
| 23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.15882600 |
| 24 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 2.04841020 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.03473546 |
| 26 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.01548301 |
| 27 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.00466426 |
| 28 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.99269655 |
| 29 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.97020040 |
| 30 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.96984977 |
| 31 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.96782693 |
| 32 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.96322326 |
| 33 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.94687108 |
| 34 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.94221279 |
| 35 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.90272003 |
| 36 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.86024959 |
| 37 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.85649745 |
| 38 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.83836968 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.83819189 |
| 40 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.83812643 |
| 41 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.83653947 |
| 42 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.83653947 |
| 43 | GATA1_19941826_ChIP-Seq_K562_Human | 1.81666695 |
| 44 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.77671302 |
| 45 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.77269143 |
| 46 | GATA2_19941826_ChIP-Seq_K562_Human | 1.72615071 |
| 47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.72300344 |
| 48 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.71886596 |
| 49 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.69485777 |
| 50 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.66266830 |
| 51 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.62934954 |
| 52 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.61767515 |
| 53 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.55650983 |
| 54 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.54940109 |
| 55 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.54940109 |
| 56 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.53373914 |
| 57 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.50452270 |
| 58 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.48453570 |
| 59 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.46050904 |
| 60 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.43324825 |
| 61 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42508449 |
| 62 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.41349382 |
| 63 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.40608810 |
| 64 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.38789172 |
| 65 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.38478799 |
| 66 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.36802750 |
| 67 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.35462969 |
| 68 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.35278462 |
| 69 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.34446595 |
| 70 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.33680245 |
| 71 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.32945606 |
| 72 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.32212041 |
| 73 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.31345780 |
| 74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.29939424 |
| 75 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.29487600 |
| 76 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.29271058 |
| 77 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.26033767 |
| 78 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.25097000 |
| 79 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.24653985 |
| 80 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.24360971 |
| 81 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.23356012 |
| 82 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.22420542 |
| 83 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.19762886 |
| 84 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.19442562 |
| 85 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.18010059 |
| 86 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.17271968 |
| 87 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.16211425 |
| 88 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.15769701 |
| 89 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.15332481 |
| 90 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14368042 |
| 91 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.14117518 |
| 92 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.13237920 |
| 93 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.13006858 |
| 94 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.12268731 |
| 95 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.11597496 |
| 96 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.10128898 |
| 97 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.09640587 |
| 98 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.09603427 |
| 99 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.09051047 |
| 100 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.08366983 |
| 101 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.07440301 |
| 102 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.07319791 |
| 103 | SPI1_23127762_ChIP-Seq_K562_Human | 1.04975628 |
| 104 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04661477 |
| 105 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.04096931 |
| 106 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.03261443 |
| 107 | CJUN_26792858_Chip-Seq_BT549_Human | 1.02788423 |
| 108 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.02340495 |
| 109 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.02200793 |
| 110 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.01770361 |
| 111 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.01719864 |
| 112 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.99509470 |
| 113 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.99341502 |
| 114 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.98393007 |
| 115 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.98016177 |
| 116 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97945317 |
| 117 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97775299 |
| 118 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97378510 |
| 119 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97211185 |
| 120 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97058408 |
| 121 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97028480 |
| 122 | GATA3_26560356_Chip-Seq_TH2_Human | 0.96983702 |
| 123 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.96520986 |
| 124 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.96270910 |
| 125 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.96075437 |
| 126 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.95699597 |
| 127 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.95599564 |
| 128 | ATF3_27146783_Chip-Seq_COLON_Human | 0.95160165 |
| 129 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.95049320 |
| 130 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.94852628 |
| 131 | MYB_26560356_Chip-Seq_TH1_Human | 0.93978019 |
| 132 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93759788 |
| 133 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.93734624 |
| 134 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93729614 |
| 135 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.93220047 |
| 136 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92746367 |
| 137 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92461213 |
| 138 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.91609342 |
| 139 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.91260960 |
| 140 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91000129 |
| 141 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.90906505 |
| 142 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.90532627 |
| 143 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90141562 |
| 144 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.89908325 |
| 145 | AR_20517297_ChIP-Seq_VCAP_Human | 0.89585402 |
| 146 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89300519 |
| 147 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.89116350 |
| 148 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.88540174 |
| 149 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.88540174 |
| 150 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.88322884 |
| 151 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.87396655 |
| 152 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.87294550 |
| 153 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.86711145 |
| 154 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.84744853 |
| 155 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.83371469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.68262122 |
| 2 | MP0005360_urolithiasis | 4.22201784 |
| 3 | MP0005365_abnormal_bile_salt | 3.34742285 |
| 4 | MP0002877_abnormal_melanocyte_morpholog | 3.21801333 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.14884514 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 2.83745156 |
| 7 | MP0003195_calcinosis | 2.72733387 |
| 8 | MP0001666_abnormal_nutrient_absorption | 2.70054586 |
| 9 | MP0010234_abnormal_vibrissa_follicle | 2.64314715 |
| 10 | MP0010352_gastrointestinal_tract_polyps | 2.56438006 |
| 11 | MP0008438_abnormal_cutaneous_collagen | 2.49751519 |
| 12 | MP0003566_abnormal_cell_adhesion | 2.42295976 |
| 13 | MP0003183_abnormal_peptide_metabolism | 2.40945978 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.36349354 |
| 15 | MP0006054_spinal_hemorrhage | 2.29432033 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.13957667 |
| 17 | MP0003868_abnormal_feces_composition | 2.06754586 |
| 18 | MP0010329_abnormal_lipoprotein_level | 1.93617128 |
| 19 | MP0005058_abnormal_lysosome_morphology | 1.91939382 |
| 20 | MP0010386_abnormal_urinary_bladder | 1.91870469 |
| 21 | MP0003724_increased_susceptibility_to | 1.87324073 |
| 22 | MP0003436_decreased_susceptibility_to | 1.86402906 |
| 23 | MP0003705_abnormal_hypodermis_morpholog | 1.77633893 |
| 24 | MP0008004_abnormal_stomach_pH | 1.77077688 |
| 25 | MP0002876_abnormal_thyroid_physiology | 1.69225441 |
| 26 | MP0009379_abnormal_foot_pigmentation | 1.67670007 |
| 27 | MP0005083_abnormal_biliary_tract | 1.66635810 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.64593649 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.63011970 |
| 30 | MP0004272_abnormal_basement_membrane | 1.62637264 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.62395359 |
| 32 | MP0005084_abnormal_gallbladder_morpholo | 1.59787525 |
| 33 | MP0005332_abnormal_amino_acid | 1.58924668 |
| 34 | MP0003091_abnormal_cell_migration | 1.58044874 |
| 35 | MP0001835_abnormal_antigen_presentation | 1.57438859 |
| 36 | MP0003866_abnormal_defecation | 1.57285927 |
| 37 | MP0005636_abnormal_mineral_homeostasis | 1.56867380 |
| 38 | MP0006276_abnormal_autonomic_nervous | 1.56838246 |
| 39 | MP0009785_altered_susceptibility_to | 1.54080837 |
| 40 | MP0003252_abnormal_bile_duct | 1.52152786 |
| 41 | MP0002796_impaired_skin_barrier | 1.52044938 |
| 42 | MP0005451_abnormal_body_composition | 1.51938705 |
| 43 | MP0005275_abnormal_skin_tensile | 1.49337087 |
| 44 | MP0009840_abnormal_foam_cell | 1.46765955 |
| 45 | MP0004947_skin_inflammation | 1.46390910 |
| 46 | MP0004043_abnormal_pH_regulation | 1.45068165 |
| 47 | MP0003186_abnormal_redox_activity | 1.43654478 |
| 48 | MP0003453_abnormal_keratinocyte_physiol | 1.43225437 |
| 49 | MP0001663_abnormal_digestive_system | 1.41342726 |
| 50 | MP0005023_abnormal_wound_healing | 1.40924301 |
| 51 | MP0002693_abnormal_pancreas_physiology | 1.40099398 |
| 52 | MP0000858_altered_metastatic_potential | 1.39868270 |
| 53 | MP0000013_abnormal_adipose_tissue | 1.39605590 |
| 54 | MP0005409_darkened_coat_color | 1.39247460 |
| 55 | MP0000538_abnormal_urinary_bladder | 1.37644175 |
| 56 | MP0005408_hypopigmentation | 1.35132200 |
| 57 | MP0002009_preneoplasia | 1.34243106 |
| 58 | MP0005666_abnormal_adipose_tissue | 1.32918355 |
| 59 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.31586538 |
| 60 | MP0005220_abnormal_exocrine_pancreas | 1.29257934 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.28694325 |
| 62 | MP0000609_abnormal_liver_physiology | 1.27184454 |
| 63 | MP0003303_peritoneal_inflammation | 1.26983412 |
| 64 | MP0001533_abnormal_skeleton_physiology | 1.26927082 |
| 65 | MP0004147_increased_porphyrin_level | 1.26528055 |
| 66 | MP0002118_abnormal_lipid_homeostasis | 1.25721848 |
| 67 | MP0002419_abnormal_innate_immunity | 1.24985718 |
| 68 | MP0002148_abnormal_hypersensitivity_rea | 1.24853998 |
| 69 | MP0004264_abnormal_extraembryonic_tissu | 1.23455725 |
| 70 | MP0008469_abnormal_protein_level | 1.21760352 |
| 71 | MP0005381_digestive/alimentary_phenotyp | 1.21339713 |
| 72 | MP0001845_abnormal_inflammatory_respons | 1.20719941 |
| 73 | MP0003828_pulmonary_edema | 1.20115929 |
| 74 | MP0005025_abnormal_response_to | 1.20086113 |
| 75 | MP0002909_abnormal_adrenal_gland | 1.19415146 |
| 76 | MP0005671_abnormal_response_to | 1.18553642 |
| 77 | MP0005000_abnormal_immune_tolerance | 1.17137407 |
| 78 | MP0010155_abnormal_intestine_physiology | 1.16710481 |
| 79 | MP0002735_abnormal_chemical_nociception | 1.16395171 |
| 80 | MP0005501_abnormal_skin_physiology | 1.16268729 |
| 81 | MP0005319_abnormal_enzyme/_coenzyme | 1.16023219 |
| 82 | MP0000604_amyloidosis | 1.15493731 |
| 83 | MP0009764_decreased_sensitivity_to | 1.14826561 |
| 84 | MP0001764_abnormal_homeostasis | 1.12612458 |
| 85 | MP0005464_abnormal_platelet_physiology | 1.11297137 |
| 86 | MP0005165_increased_susceptibility_to | 1.11050625 |
| 87 | MP0001664_abnormal_digestion | 1.09508805 |
| 88 | MP0002971_abnormal_brown_adipose | 1.08981524 |
| 89 | MP0004185_abnormal_adipocyte_glucose | 1.08307315 |
| 90 | MP0003950_abnormal_plasma_membrane | 1.07731582 |
| 91 | MP0002933_joint_inflammation | 1.07600143 |
| 92 | MP0006082_CNS_inflammation | 1.06141521 |
| 93 | MP0002078_abnormal_glucose_homeostasis | 1.05049093 |
| 94 | MP0001944_abnormal_pancreas_morphology | 1.04981173 |
| 95 | MP0005387_immune_system_phenotype | 1.04682107 |
| 96 | MP0001790_abnormal_immune_system | 1.04682107 |
| 97 | MP0001873_stomach_inflammation | 1.04475835 |
| 98 | MP0003191_abnormal_cellular_cholesterol | 1.03773641 |
| 99 | MP0009780_abnormal_chondrocyte_physiolo | 1.03629566 |
| 100 | MP0003763_abnormal_thymus_physiology | 1.03449512 |
| 101 | MP0001851_eye_inflammation | 1.03365562 |
| 102 | MP0005379_endocrine/exocrine_gland_phen | 1.02007972 |
| 103 | MP0001216_abnormal_epidermal_layer | 1.01354472 |
| 104 | MP0001800_abnormal_humoral_immune | 1.00714934 |
| 105 | MP0001756_abnormal_urination | 1.00283357 |
| 106 | MP0002452_abnormal_antigen_presenting | 0.99708385 |
| 107 | MP0001765_abnormal_ion_homeostasis | 0.99234864 |
| 108 | MP0005166_decreased_susceptibility_to | 0.99207464 |
| 109 | MP0006036_abnormal_mitochondrial_physio | 0.98718422 |
| 110 | MP0001542_abnormal_bone_strength | 0.97843335 |
| 111 | MP0000249_abnormal_blood_vessel | 0.96743866 |
| 112 | MP0002060_abnormal_skin_morphology | 0.96471244 |
| 113 | MP0001986_abnormal_taste_sensitivity | 0.95962041 |
| 114 | MP0008260_abnormal_autophagy | 0.94963278 |
| 115 | MP0002006_tumorigenesis | 0.93097452 |
| 116 | MP0001958_emphysema | 0.92207506 |
| 117 | MP0009697_abnormal_copulation | 0.91694159 |
| 118 | MP0001661_extended_life_span | 0.91581667 |
| 119 | MP0004782_abnormal_surfactant_physiolog | 0.91493381 |
| 120 | MP0000343_altered_response_to | 0.90390675 |
| 121 | MP0002723_abnormal_immune_serum | 0.90384481 |
| 122 | MP0002733_abnormal_thermal_nociception | 0.88443602 |
| 123 | MP0002132_abnormal_respiratory_system | 0.88374087 |
| 124 | MP0002420_abnormal_adaptive_immunity | 0.87353352 |
| 125 | MP0001819_abnormal_immune_cell | 0.87162160 |
| 126 | MP0004019_abnormal_vitamin_homeostasis | 0.86685290 |
| 127 | MP0005535_abnormal_body_temperature | 0.86587908 |
| 128 | MP0005375_adipose_tissue_phenotype | 0.86332843 |
| 129 | MP0009642_abnormal_blood_homeostasis | 0.86257098 |
| 130 | MP0002736_abnormal_nociception_after | 0.85202853 |
| 131 | MP0001881_abnormal_mammary_gland | 0.83683267 |
| 132 | MP0004883_abnormal_blood_vessel | 0.83528713 |
| 133 | MP0000490_abnormal_crypts_of | 0.83488468 |
| 134 | MP0002998_abnormal_bone_remodeling | 0.83252074 |
| 135 | MP0000462_abnormal_digestive_system | 0.82486676 |
| 136 | MP0003448_altered_tumor_morphology | 0.82037268 |
| 137 | MP0002166_altered_tumor_susceptibility | 0.81983204 |
| 138 | MP0001968_abnormal_touch/_nociception | 0.81857723 |
| 139 | MP0000477_abnormal_intestine_morphology | 0.80493145 |
| 140 | MP0002896_abnormal_bone_mineralization | 0.80349934 |
| 141 | MP0004270_analgesia | 0.80002778 |
| 142 | MP0005164_abnormal_response_to | 0.79415780 |
| 143 | MP0010678_abnormal_skin_adnexa | 0.79003942 |
| 144 | MP0005621_abnormal_cell_physiology | 0.78801525 |
| 145 | MP0009763_increased_sensitivity_to | 0.78745930 |
| 146 | MP0000685_abnormal_immune_system | 0.78405915 |
| 147 | MP0009333_abnormal_splenocyte_physiolog | 0.72449235 |
| 148 | MP0001879_abnormal_lymphatic_vessel | 0.72153719 |
| 149 | MP0003279_aneurysm | 0.71672340 |
| 150 | MP0001915_intracranial_hemorrhage | 0.68658381 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.09555668 |
| 2 | Increased mean platelet volume (HP:0011877) | 4.07808117 |
| 3 | Abnormal platelet volume (HP:0011876) | 3.77357166 |
| 4 | Menorrhagia (HP:0000132) | 3.75403440 |
| 5 | Abnormal tarsal ossification (HP:0008369) | 3.41999184 |
| 6 | Prolonged bleeding time (HP:0003010) | 3.39982375 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 3.34166567 |
| 8 | Hypothermia (HP:0002045) | 3.15663734 |
| 9 | Beaking of vertebral bodies (HP:0004568) | 3.12013941 |
| 10 | Purpura (HP:0000979) | 3.00036820 |
| 11 | Conjugated hyperbilirubinemia (HP:0002908) | 2.95571697 |
| 12 | Gingival bleeding (HP:0000225) | 2.91582662 |
| 13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.79970152 |
| 14 | Premature rupture of membranes (HP:0001788) | 2.78264456 |
| 15 | Fat malabsorption (HP:0002630) | 2.77684769 |
| 16 | Hypobetalipoproteinemia (HP:0003563) | 2.76111926 |
| 17 | Epistaxis (HP:0000421) | 2.73272989 |
| 18 | Abnormality of the intrinsic pathway (HP:0010989) | 2.73004201 |
| 19 | Irregular epiphyses (HP:0010582) | 2.72887016 |
| 20 | Polycythemia (HP:0001901) | 2.71915419 |
| 21 | Epiphyseal dysplasia (HP:0002656) | 2.66456974 |
| 22 | Mucopolysacchariduria (HP:0008155) | 2.65751716 |
| 23 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.65751716 |
| 24 | Protrusio acetabuli (HP:0003179) | 2.64775940 |
| 25 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.64365417 |
| 26 | Abnormal platelet function (HP:0011869) | 2.64287440 |
| 27 | Impaired platelet aggregation (HP:0003540) | 2.64287440 |
| 28 | Arterial tortuosity (HP:0005116) | 2.64063737 |
| 29 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.61676846 |
| 30 | Osteolytic defects of the hand bones (HP:0009699) | 2.61676846 |
| 31 | Intrahepatic cholestasis (HP:0001406) | 2.61058080 |
| 32 | Hyperlipoproteinemia (HP:0010980) | 2.60975652 |
| 33 | Xanthomatosis (HP:0000991) | 2.60743562 |
| 34 | Flat acetabular roof (HP:0003180) | 2.59428874 |
| 35 | Cupped ribs (HP:0000887) | 2.59288852 |
| 36 | Petechiae (HP:0000967) | 2.58647829 |
| 37 | Tetraparesis (HP:0002273) | 2.57972392 |
| 38 | Generalized aminoaciduria (HP:0002909) | 2.56961134 |
| 39 | Abnormal foot bone ossification (HP:0010675) | 2.56914178 |
| 40 | Complement deficiency (HP:0004431) | 2.55701993 |
| 41 | Abnormality of complement system (HP:0005339) | 2.55584883 |
| 42 | Hypoglycemic coma (HP:0001325) | 2.55428487 |
| 43 | Dysostosis multiplex (HP:0000943) | 2.54245662 |
| 44 | Abnormality of the common coagulation pathway (HP:0010990) | 2.54198157 |
| 45 | Vascular tortuosity (HP:0004948) | 2.50973245 |
| 46 | Acute encephalopathy (HP:0006846) | 2.50200611 |
| 47 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.48911964 |
| 48 | Ketoacidosis (HP:0001993) | 2.48659465 |
| 49 | Ankyloglossia (HP:0010296) | 2.44784489 |
| 50 | Hepatic necrosis (HP:0002605) | 2.42944019 |
| 51 | Aortic dissection (HP:0002647) | 2.40966951 |
| 52 | Prolonged partial thromboplastin time (HP:0003645) | 2.38269063 |
| 53 | Systemic lupus erythematosus (HP:0002725) | 2.36377130 |
| 54 | Thoracolumbar scoliosis (HP:0002944) | 2.34845768 |
| 55 | Acute necrotizing encephalopathy (HP:0006965) | 2.33826756 |
| 56 | Mitral stenosis (HP:0001718) | 2.32837024 |
| 57 | Aortic aneurysm (HP:0004942) | 2.32697510 |
| 58 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.32172848 |
| 59 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.32172848 |
| 60 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.32172848 |
| 61 | Eczematoid dermatitis (HP:0000976) | 2.32010892 |
| 62 | Protuberant abdomen (HP:0001538) | 2.31339827 |
| 63 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.31116395 |
| 64 | Poikilocytosis (HP:0004447) | 2.30937388 |
| 65 | Ketosis (HP:0001946) | 2.30161495 |
| 66 | Hemorrhage of the eye (HP:0011885) | 2.28077400 |
| 67 | Termporal pattern (HP:0011008) | 2.25488711 |
| 68 | Insidious onset (HP:0003587) | 2.25488711 |
| 69 | Irregular vertebral endplates (HP:0003301) | 2.24990341 |
| 70 | Abnormality of the lumbar spine (HP:0100712) | 2.24491066 |
| 71 | Hepatocellular necrosis (HP:0001404) | 2.24177539 |
| 72 | Reduced antithrombin III activity (HP:0001976) | 2.20709374 |
| 73 | Vertebral compression fractures (HP:0002953) | 2.19559189 |
| 74 | Glomerulonephritis (HP:0000099) | 2.16285042 |
| 75 | Abnormality of urine glucose concentration (HP:0011016) | 2.15882722 |
| 76 | Glycosuria (HP:0003076) | 2.15882722 |
| 77 | Papillary thyroid carcinoma (HP:0002895) | 2.14640132 |
| 78 | Abnormality of purine metabolism (HP:0004352) | 2.13775842 |
| 79 | Symptomatic seizures (HP:0011145) | 2.13546848 |
| 80 | Neuroendocrine neoplasm (HP:0100634) | 2.11191365 |
| 81 | Spontaneous hematomas (HP:0007420) | 2.10832982 |
| 82 | Progressive macrocephaly (HP:0004481) | 2.09536708 |
| 83 | Ileus (HP:0002595) | 2.09340246 |
| 84 | Chronic diarrhea (HP:0002028) | 2.09243433 |
| 85 | Axonal loss (HP:0003447) | 2.08764330 |
| 86 | Recurrent bacterial skin infections (HP:0005406) | 2.08257729 |
| 87 | Pheochromocytoma (HP:0002666) | 2.07559487 |
| 88 | Hyperphosphaturia (HP:0003109) | 2.07104217 |
| 89 | Steatorrhea (HP:0002570) | 2.06857311 |
| 90 | Cardiovascular calcification (HP:0011915) | 2.06323857 |
| 91 | Hydroxyprolinuria (HP:0003080) | 2.06027532 |
| 92 | Abnormality of proline metabolism (HP:0010907) | 2.06027532 |
| 93 | Mitochondrial inheritance (HP:0001427) | 2.05810299 |
| 94 | Deep venous thrombosis (HP:0002625) | 2.05686605 |
| 95 | Dilatation of the ascending aorta (HP:0005111) | 2.05374297 |
| 96 | Abnormality of oral frenula (HP:0000190) | 2.05359706 |
| 97 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.04579940 |
| 98 | Abdominal distention (HP:0003270) | 2.03748115 |
| 99 | Recurrent abscess formation (HP:0002722) | 2.03256547 |
| 100 | Abnormality of the vertebral endplates (HP:0005106) | 2.02575841 |
| 101 | Epidermoid cyst (HP:0200040) | 1.99820479 |
| 102 | Cerebral edema (HP:0002181) | 1.98956625 |
| 103 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.97476910 |
| 104 | Hyperactive renin-angiotensin system (HP:0000841) | 1.97279724 |
| 105 | Hyperbilirubinemia (HP:0002904) | 1.97017341 |
| 106 | Metaphyseal dysplasia (HP:0100255) | 1.96801394 |
| 107 | Small epiphyses (HP:0010585) | 1.95606069 |
| 108 | Right ventricular cardiomyopathy (HP:0011663) | 1.95429666 |
| 109 | Conjunctival hamartoma (HP:0100780) | 1.95235192 |
| 110 | Acanthocytosis (HP:0001927) | 1.95196009 |
| 111 | Delayed epiphyseal ossification (HP:0002663) | 1.95079160 |
| 112 | Exocrine pancreatic insufficiency (HP:0001738) | 1.94680497 |
| 113 | Myocardial infarction (HP:0001658) | 1.93921223 |
| 114 | Vascular calcification (HP:0004934) | 1.93153747 |
| 115 | Pancreatitis (HP:0001733) | 1.92785452 |
| 116 | Irritability (HP:0000737) | 1.92457794 |
| 117 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.90363346 |
| 118 | Abnormality of the Achilles tendon (HP:0005109) | 1.90132550 |
| 119 | Disinhibition (HP:0000734) | 1.89011472 |
| 120 | Autoamputation (HP:0001218) | 1.88992776 |
| 121 | Hyperammonemia (HP:0001987) | 1.88855867 |
| 122 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.88844784 |
| 123 | Hypoglycemic seizures (HP:0002173) | 1.87923352 |
| 124 | Back pain (HP:0003418) | 1.87754311 |
| 125 | Abnormal cartilage morphology (HP:0002763) | 1.87254636 |
| 126 | Hypotension (HP:0002615) | 1.84389095 |
| 127 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.83840669 |
| 128 | Growth hormone excess (HP:0000845) | 1.83688065 |
| 129 | Agitation (HP:0000713) | 1.83020040 |
| 130 | Gout (HP:0001997) | 1.81933178 |
| 131 | Thin bony cortex (HP:0002753) | 1.80837204 |
| 132 | Flattened epiphyses (HP:0003071) | 1.80206583 |
| 133 | Joint swelling (HP:0001386) | 1.79971697 |
| 134 | Flat capital femoral epiphysis (HP:0003370) | 1.79762092 |
| 135 | Joint hemorrhage (HP:0005261) | 1.79332708 |
| 136 | Renal tubular acidosis (HP:0001947) | 1.79000451 |
| 137 | Hyperparathyroidism (HP:0000843) | 1.77815384 |
| 138 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.77585413 |
| 139 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.77585413 |
| 140 | Abnormal protein glycosylation (HP:0012346) | 1.77585413 |
| 141 | Abnormal glycosylation (HP:0012345) | 1.77585413 |
| 142 | Nephritis (HP:0000123) | 1.77220315 |
| 143 | Cholecystitis (HP:0001082) | 1.76533567 |
| 144 | Abnormal gallbladder physiology (HP:0012438) | 1.76533567 |
| 145 | Abnormal epiphyseal ossification (HP:0010656) | 1.76096313 |
| 146 | Cerebral hemorrhage (HP:0001342) | 1.75646283 |
| 147 | Enlarged epiphyses (HP:0010580) | 1.75539127 |
| 148 | Late onset (HP:0003584) | 1.74964033 |
| 149 | Papilledema (HP:0001085) | 1.74712095 |
| 150 | Metaphyseal irregularity (HP:0003025) | 1.74584413 |
| 151 | Nausea (HP:0002018) | 1.74499185 |
| 152 | Abnormality of macrophages (HP:0004311) | 1.74109941 |
| 153 | Arthropathy (HP:0003040) | 1.74052196 |
| 154 | Wormian bones (HP:0002645) | 1.73636712 |
| 155 | Hypolipoproteinemia (HP:0010981) | 1.73147131 |
| 156 | Increased CSF lactate (HP:0002490) | 1.73044162 |
| 157 | Alkalosis (HP:0001948) | 1.72536201 |
| 158 | Malnutrition (HP:0004395) | 1.72402605 |
| 159 | Curly hair (HP:0002212) | 1.71502937 |
| 160 | Orthostatic hypotension (HP:0001278) | 1.71470365 |
| 161 | Asymmetry of the thorax (HP:0001555) | 1.71271942 |
| 162 | Gastrointestinal stroma tumor (HP:0100723) | 1.69980084 |
| 163 | Coarse hair (HP:0002208) | 1.69844126 |
| 164 | Bone pain (HP:0002653) | 1.69472193 |
| 165 | Fatigue (HP:0012378) | 1.66821972 |
| 166 | Interstitial pulmonary disease (HP:0006530) | 1.65179629 |
| 167 | Glucose intolerance (HP:0000833) | 1.64657223 |
| 168 | Abnormality of carpal bone ossification (HP:0006257) | 1.64657105 |
| 169 | Chondrocalcinosis (HP:0000934) | 1.62676217 |
| 170 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.62483412 |
| 171 | Abnormality of the gastric mucosa (HP:0004295) | 1.61475521 |
| 172 | Aneurysm (HP:0002617) | 1.61261985 |
| 173 | Abnormal glucose tolerance (HP:0001952) | 1.61105463 |
| 174 | Hypercholesterolemia (HP:0003124) | 1.60983828 |
| 175 | Male infertility (HP:0003251) | 1.60547256 |
| 176 | Multiple lipomas (HP:0001012) | 1.59264264 |
| 177 | Distal lower limb amyotrophy (HP:0008944) | 1.59159273 |
| 178 | Abnormal delivery (HP:0001787) | 1.58901398 |
| 179 | Atrophic scars (HP:0001075) | 1.58147970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 3.44168334 |
| 2 | LMTK2 | 3.07661531 |
| 3 | BMPR2 | 2.76631589 |
| 4 | MST4 | 2.74066328 |
| 5 | ARAF | 2.61442566 |
| 6 | MAP3K12 | 2.58047801 |
| 7 | LIMK1 | 2.57547261 |
| 8 | ERN1 | 2.44607691 |
| 9 | NME2 | 2.37005834 |
| 10 | PIM2 | 2.34534480 |
| 11 | PRPF4B | 2.31934555 |
| 12 | TESK1 | 2.29633921 |
| 13 | EIF2AK3 | 2.24015440 |
| 14 | MYLK | 2.19385038 |
| 15 | SCYL2 | 2.00909361 |
| 16 | EPHA2 | 1.99056962 |
| 17 | TAOK3 | 1.92914877 |
| 18 | IRAK4 | 1.92307281 |
| 19 | NME1 | 1.90787836 |
| 20 | ACVR1B | 1.86243097 |
| 21 | MAP3K2 | 1.76142743 |
| 22 | RIPK1 | 1.71686569 |
| 23 | SIK3 | 1.66234345 |
| 24 | MST1R | 1.63883381 |
| 25 | RIPK4 | 1.62213241 |
| 26 | TRIB3 | 1.55570112 |
| 27 | PDGFRA | 1.50914244 |
| 28 | CASK | 1.43818613 |
| 29 | BLK | 1.43378017 |
| 30 | KSR2 | 1.41654326 |
| 31 | GRK5 | 1.38785307 |
| 32 | JAK1 | 1.34842184 |
| 33 | BCKDK | 1.33631489 |
| 34 | TYK2 | 1.31475672 |
| 35 | TRPM7 | 1.28634443 |
| 36 | CSNK1G3 | 1.28298606 |
| 37 | MAP2K7 | 1.27791691 |
| 38 | TBK1 | 1.22560389 |
| 39 | CDK6 | 1.21148464 |
| 40 | CSNK1G2 | 1.20068855 |
| 41 | STK3 | 1.17945779 |
| 42 | GRK6 | 1.17266680 |
| 43 | EIF2AK1 | 1.17078096 |
| 44 | TESK2 | 1.15181313 |
| 45 | FLT3 | 1.11307005 |
| 46 | SYK | 1.10376173 |
| 47 | EEF2K | 1.09995860 |
| 48 | ABL2 | 1.09307988 |
| 49 | NTRK1 | 1.08500377 |
| 50 | TEC | 1.08088262 |
| 51 | PKN2 | 1.07998516 |
| 52 | DYRK2 | 1.07445445 |
| 53 | ILK | 1.07039414 |
| 54 | EPHB1 | 1.06334351 |
| 55 | BCR | 1.05874096 |
| 56 | MAP3K14 | 1.05640888 |
| 57 | MAP2K1 | 1.05394543 |
| 58 | PRKG2 | 1.04621881 |
| 59 | MAP3K6 | 1.04596581 |
| 60 | PAK4 | 1.03345987 |
| 61 | NEK9 | 1.02540104 |
| 62 | ICK | 1.01650099 |
| 63 | ERBB3 | 1.01219462 |
| 64 | BMX | 1.01092109 |
| 65 | TGFBR2 | 0.99635758 |
| 66 | MET | 0.99022506 |
| 67 | OXSR1 | 0.98632342 |
| 68 | MARK1 | 0.97635520 |
| 69 | MINK1 | 0.97615534 |
| 70 | NEK1 | 0.93942941 |
| 71 | PLK2 | 0.93883538 |
| 72 | KIT | 0.93540166 |
| 73 | CAMKK2 | 0.92069672 |
| 74 | CSNK1A1L | 0.92040314 |
| 75 | KSR1 | 0.91428625 |
| 76 | MAP3K4 | 0.89490608 |
| 77 | EPHA3 | 0.87227542 |
| 78 | MATK | 0.84446302 |
| 79 | MAP4K1 | 0.83794146 |
| 80 | PIK3CG | 0.83666057 |
| 81 | PBK | 0.83313686 |
| 82 | MAP3K10 | 0.81740355 |
| 83 | INSRR | 0.81236872 |
| 84 | MAP3K1 | 0.81014000 |
| 85 | BRAF | 0.80855368 |
| 86 | STK24 | 0.80135097 |
| 87 | LATS2 | 0.78444191 |
| 88 | BMPR1B | 0.78283476 |
| 89 | PAK2 | 0.77956265 |
| 90 | YES1 | 0.75957159 |
| 91 | ERBB4 | 0.75743080 |
| 92 | PTK2 | 0.74518341 |
| 93 | CSNK1G1 | 0.74012675 |
| 94 | MAP3K11 | 0.73984277 |
| 95 | MAPK11 | 0.73878595 |
| 96 | IRAK3 | 0.72754272 |
| 97 | MAP3K13 | 0.72132533 |
| 98 | TTN | 0.71293662 |
| 99 | WNK4 | 0.70249630 |
| 100 | CLK1 | 0.69857774 |
| 101 | MAP3K9 | 0.69838148 |
| 102 | FER | 0.69514062 |
| 103 | ZAP70 | 0.68664069 |
| 104 | PIK3CA | 0.68241243 |
| 105 | JAK3 | 0.67224831 |
| 106 | MAP2K2 | 0.67051958 |
| 107 | FGFR3 | 0.66122136 |
| 108 | PRKCE | 0.65069711 |
| 109 | MAP3K3 | 0.64955322 |
| 110 | CSK | 0.64208661 |
| 111 | PTK6 | 0.64085447 |
| 112 | LYN | 0.63396136 |
| 113 | LRRK2 | 0.62504027 |
| 114 | MAPK4 | 0.61732137 |
| 115 | PDGFRB | 0.61520280 |
| 116 | JAK2 | 0.60120447 |
| 117 | MAPKAPK3 | 0.59756503 |
| 118 | CSF1R | 0.59644987 |
| 119 | RET | 0.56975542 |
| 120 | PDPK1 | 0.56210779 |
| 121 | TAOK2 | 0.54872946 |
| 122 | MAP2K3 | 0.54209709 |
| 123 | MAP2K4 | 0.53011848 |
| 124 | FGFR4 | 0.52935220 |
| 125 | CDK19 | 0.52691377 |
| 126 | FGR | 0.52301999 |
| 127 | STK16 | 0.51826905 |
| 128 | ADRBK2 | 0.51821913 |
| 129 | BTK | 0.51537306 |
| 130 | MAP3K8 | 0.50539002 |
| 131 | PDK1 | 0.50052633 |
| 132 | BRSK2 | 0.49822249 |
| 133 | RAF1 | 0.49819204 |
| 134 | RPS6KA4 | 0.48923675 |
| 135 | DDR2 | 0.47813291 |
| 136 | PRKCI | 0.47695749 |
| 137 | CCNB1 | 0.47022083 |
| 138 | ITK | 0.45031812 |
| 139 | SIK1 | 0.44834658 |
| 140 | STK39 | 0.44754925 |
| 141 | PRKCD | 0.44116275 |
| 142 | STK10 | 0.43782047 |
| 143 | CDK14 | 0.43492022 |
| 144 | DMPK | 0.42438604 |
| 145 | IRAK1 | 0.42083627 |
| 146 | MAPKAPK2 | 0.39221233 |
| 147 | MOS | 0.35012191 |
| 148 | CDC42BPA | 0.32971427 |
| 149 | HCK | 0.32004174 |
| 150 | CDK12 | 0.31292508 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.63978996 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.66019764 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.28804272 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.94236201 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.40183967 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.26274851 |
| 7 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.20156293 |
| 8 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.18433289 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.14096980 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.91027018 |
| 11 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.89150520 |
| 12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.85209977 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.81891599 |
| 14 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.80454827 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 1.76894276 |
| 16 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.73239570 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.72198207 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.71402452 |
| 19 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.68309156 |
| 20 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.67773439 |
| 21 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.66668945 |
| 22 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.57705873 |
| 23 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.54898178 |
| 24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.54504373 |
| 25 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.53852835 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.51290130 |
| 27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.45894261 |
| 28 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.38867187 |
| 29 | Platelet activation_Homo sapiens_hsa04611 | 1.38826483 |
| 30 | Phagosome_Homo sapiens_hsa04145 | 1.37429704 |
| 31 | Parkinsons disease_Homo sapiens_hsa05012 | 1.36868180 |
| 32 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.34937744 |
| 33 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.31110780 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.30290898 |
| 35 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.29990253 |
| 36 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.28939809 |
| 37 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.27702984 |
| 38 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.21281612 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.20353035 |
| 40 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.20059088 |
| 41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.17659945 |
| 42 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.15397969 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.14783055 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14634767 |
| 45 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.11246660 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.11138578 |
| 47 | Alzheimers disease_Homo sapiens_hsa05010 | 1.11116096 |
| 48 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.10253798 |
| 49 | Lysosome_Homo sapiens_hsa04142 | 1.06535989 |
| 50 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.03111699 |
| 51 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.02736187 |
| 52 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.01633007 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.01607471 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.01253144 |
| 55 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.99783250 |
| 56 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.99208344 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98624657 |
| 58 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.97766915 |
| 59 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.96770753 |
| 60 | Pertussis_Homo sapiens_hsa05133 | 0.96455514 |
| 61 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.93862560 |
| 62 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.93562715 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.93230819 |
| 64 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.89696505 |
| 65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89633513 |
| 66 | Proteasome_Homo sapiens_hsa03050 | 0.89180159 |
| 67 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.88328151 |
| 68 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.86159272 |
| 69 | Focal adhesion_Homo sapiens_hsa04510 | 0.85765566 |
| 70 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84448324 |
| 71 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.83355712 |
| 72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82480659 |
| 73 | Mineral absorption_Homo sapiens_hsa04978 | 0.82334839 |
| 74 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.82201814 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.80984448 |
| 76 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.79738900 |
| 77 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.79484154 |
| 78 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.79110937 |
| 79 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78411676 |
| 80 | Legionellosis_Homo sapiens_hsa05134 | 0.77362006 |
| 81 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.74908801 |
| 82 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.73177209 |
| 83 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.72720617 |
| 84 | Bile secretion_Homo sapiens_hsa04976 | 0.72405388 |
| 85 | Shigellosis_Homo sapiens_hsa05131 | 0.72400552 |
| 86 | Prion diseases_Homo sapiens_hsa05020 | 0.71559969 |
| 87 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.69669746 |
| 88 | Tuberculosis_Homo sapiens_hsa05152 | 0.65775320 |
| 89 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.65223078 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.64918182 |
| 91 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63953545 |
| 92 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.62426720 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59989402 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.59764089 |
| 95 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.59666210 |
| 96 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.59226609 |
| 97 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.58491700 |
| 98 | Adherens junction_Homo sapiens_hsa04520 | 0.57983009 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56970854 |
| 100 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.56960281 |
| 101 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56948597 |
| 102 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.56846378 |
| 103 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56747124 |
| 104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.56038654 |
| 105 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.55620175 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.54141294 |
| 107 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.54021342 |
| 108 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.53971413 |
| 109 | Endometrial cancer_Homo sapiens_hsa05213 | 0.53590411 |
| 110 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.52698594 |
| 111 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51872288 |
| 112 | Leishmaniasis_Homo sapiens_hsa05140 | 0.51581213 |
| 113 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51120947 |
| 114 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49615366 |
| 115 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49556280 |
| 116 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.49520843 |
| 117 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.49495797 |
| 118 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.49012857 |
| 119 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48531972 |
| 120 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47889740 |
| 121 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47882252 |
| 122 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47674200 |
| 123 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47613939 |
| 124 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.46912058 |
| 125 | Glioma_Homo sapiens_hsa05214 | 0.45951995 |
| 126 | Huntingtons disease_Homo sapiens_hsa05016 | 0.45267960 |
| 127 | Hepatitis B_Homo sapiens_hsa05161 | 0.44792742 |
| 128 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.43524387 |
| 129 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.43488525 |
| 130 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43365196 |
| 131 | Salmonella infection_Homo sapiens_hsa05132 | 0.42779573 |
| 132 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.42495894 |
| 133 | Retinol metabolism_Homo sapiens_hsa00830 | 0.41023749 |
| 134 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39885776 |
| 135 | Hepatitis C_Homo sapiens_hsa05160 | 0.38221255 |
| 136 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37184135 |
| 137 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.36090159 |
| 138 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.34993205 |
| 139 | Thyroid cancer_Homo sapiens_hsa05216 | 0.34953744 |
| 140 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.34404777 |
| 141 | Carbon metabolism_Homo sapiens_hsa01200 | 0.33287808 |
| 142 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.32774868 |
| 143 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31551218 |
| 144 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.30919498 |

